Related Experiment Video
Updated: Jan 16, 2026
10:47
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
9.2K
Exploring CPP Enhanced Hypoxia Targeting: An Approach Using Radiolabeled 2-nitroimidazole TAT Conjugate.
Sweety Mittal1, Akanksha Jain1, Ashwini Babu2
1Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Drug Development Research
|January 15, 2026
Summary
Cell-penetrating peptides (CPPs) conjugated with nitroimidazole show promise for targeting hypoxic tumors. However, hypoxia negatively impacts CPP uptake, limiting their application in hypoxia-targeted drug delivery.
Area of Science:
- Biomedical Engineering
- Molecular Imaging
- Drug Delivery
Background:
- Cell-penetrating peptides (CPPs) facilitate intracellular delivery.
- Targeting tumor hypoxia is crucial for effective cancer therapy.
- 2-nitroimidazole derivatives are hypoxia-sensitive moieties.
Purpose of the Study:
- To develop and evaluate a novel radiolabeled CPP conjugate for targeting tumor hypoxia.
- To assess the in vitro and in vivo performance of the conjugate.
Main Methods:
- Synthesis of iodine-125 labeled 2-nitroimidazole conjugated TAT peptide ([125I]I-TAT-2-NIM).
- In vitro studies using CHO cells under hypoxic and normoxic conditions.
- In vivo studies in tumor-bearing models to evaluate tumor uptake and retention.
Main Results:
- [125I]I-TAT-2-NIM showed significantly higher uptake in hypoxic cells compared to [125I]I-TAT in vitro.
- Hypoxia negatively influenced the cellular uptake of radiolabeled TAT peptides.
- In vivo, [125I]I-TAT-2-NIM demonstrated tumor uptake and retention with a tumor/muscle ratio > 2.
Conclusions:
- The 2-nitroimidazole moiety enhances hypoxic cell targeting of CPPs.
- Hypoxia-induced reduction in CPP uptake presents a limitation for hypoxia-targeted delivery.
- Further optimization is needed to overcome hypoxia's negative impact on CPPs for effective tumor targeting.
